Patent ID: 8012697

Claim:
A method for the diagnosis of prostate or colon cancer comprising analyzing a sample for the presence and/or amount of annexin A3 by detecting annexin A3 with an antibody specific for annexin A3 which has essentially no crossreactivity against other annexins, wherein the antibody is selected from an antibody produced by the hybridoma cell lines tgc 5 ProII6G7(DSM ACC2778), tgc 6 ProIII1G11(DSM ACC2779), tgc 7 ProVII5C5(DSM ACC2780), tgc 8 ProIII1E1(DSM ACC2781), tgc 13 ProI/5G9, tgc 12 ProIII/4B11, tgc 14 ProVIII/3D7, or an antibody which binds to the same epitopes on annexin A3 as bound by the antibodies produced by said hybridoma cell lines.